Bubae
18時間前
New 8K filed on January 23rd. If you all want to see the need for the split and the next offering take a look at the new agreements. Again we see the little carve out for Shawn Leon"s new property venture BH Properties Fund, LLC. Life is good when you are landlord and make decisions as the tenant as well. the seller, John David Elam, was the previous owner of Edgewater Recovery Centers and was busted by the justice department resulting in a $2.2 million settlement over false laboratory claims. Post# 51454 for details and links. The DEF 14C has been filed though I have not seen it filed with FINRA yet. it is supposed to be filed with FINRA no less than 10 days prior to the split. The new regulation A offering should closely follow the split. Shawn Leon is getting pinched once again with the defaulted debt.
Date of Report (Date of earliest event reported): January 9, 2025
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000792935/000190359625000048/grst_8k.htm
On January 9, 2025, in connection with the consummation of the acquisition of the assets of Edgewater Recovery Centers, LLC (“ECI”) described under Item 2.01 below of this Current Report on Form 8-K by ARIA Kentucky, LLC (“ARIA Kentucky”), a wholly owned subsidiary of Ethema Health Corporation (the “Company”), pursuant to the Asset Purchase Agreement, dated October 22, 2024 (the “APA”), by and among ECI, its sole member John David Elam (the “Seller”) and ARIA Kentucky, ARIA Kentucky entered into the following leases with certain subsidiaries of BH Properties Fund, LLC (“BH Properties”), a fund controlled by the CEO of the Company, Shawn Leon, a related party:
Bubae
Re: None
Tuesday, November 19, 2024 12:19:54 AM
Post# 51454 of 51846
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175406884&txt2find=Elam
Looks like there is a reason why Ethema Health was able to acquire the Kentucky treatment centers for essentially nothing. Aside from the fact that the previous owners of the Edgewater Recovery was hit with a $2.2 million settlement over false laboratory claims I found a couple of articles dated in the past month suggesting that the addiction recovery industry in Kentucky is under pressure by industry-wide reimbursement cuts for Medicaid. Citing the Edgewater letter of intent press release of July 12th "The Kentucky operation primarily provides care to Medicaid insured clients." Beginning to see the need for the reverse split and the regulation "A" offering that is pending?
Bubae
18時間前
This stock is all about the insiders who hold more than 5 million in dent. The reverse split 8k also talks about increasing the preferred share count. These people are working a plan and post split you can count on another regulation A offering to be filed. Shawn Leon spent heavily promoting the last two year old regulation A offering and it failed.
Bubae
Re: declaes post# 51789
Monday, January 13, 2025 3:41:18 PM
Post# 51791 of 51845
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175658822&txt2find=cash%20burn
I don't know why you keep posting that false nonsense. No new cash was realized with the Leons debt conversions to equity that resulted in a more than 100% dilution of the stock. Along with other borrowing for Q3 the Leons had to loan the company $250K to get through the quarter. If they can't get the reverse split and regulation A offering in order the Leons may need to break out the check books for some serious money soon. That $600K note alone that matured on November 15th is earning 24% default interest per month according to the filing.
Bubae
Re: None
Thursday, November 21, 2024 11:18:38 AM
Post# 51480 of 51845
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175420557&txt2find=NYSE
Go to 11:20 into the July podcast where Shawn Leon starts talking about the use of proceeds from the regulation "A" offering whos shares would be exempt from registration and immediately free trading. We see $500K to support the operations at Boca and another $1 million to support the operations in Kentucky. He goes on to talk about the new convertible preferred shares that he claims he will be selling to investors. I do not see any real investors buying preferred shares of this scheme and they never have before. What I see is that new bucket of preferred shares is to convert the balance of the millions of so called "friendly" debt Shawn Leon talked about back in the January podcast. June 15th video at about 25:40 into the podcast be begins to talk about the NYSE and a $3 price, consolidation, and related party stock conversions. The January podcast talks specifically to the $4 million additional debt to be converted at about 24:10 into the segment. That friendly debt to the so called advisers is now close to $5 million.
declaes
22時間前
WARNING!!!!! Do your due dilligence before believing the bashers that have been here for over 3 years without holding any shares. GRST has announced an upcoming reverse split to move to the OTCQB to attract more and bigger investors that can't invest on the PINKS but will on the OTCQB.
GRST announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
1 year ago we were arguing the GRST bedcount. Bashers said it were 40 beds others said 60 beds. Bashers said GRST would never have 60 beds. Today GRST has 150 beds OPEN an 440 beds to open in 2025. Projecting 5000 beds by 2027.
Bashers said GRST would never get 1,000,000 revenues. The last report GRST reported over 5,000,000 revenues and going for 25,000,000 revenues in 2025.
Bashers said GRST would never make a net profit 📈. In 2024 GRST made 1.1 mil net profit with 5mil rev. With 25mil rev we are looking for 6mil net profit.
Bashers said Mr. Leon CEO was only holding GRST open to steal from stockholders. He did not invest anything in GRST. In 2024 Mr. Leon bought 53% of the outstanding shares. And now Mr. Leon provided a personal guarantee for $3,000,000.00 of the bank debt assumed by ARIA Kentucky.
WARNING!!! Do your own DD. You don't have to believe me. I'm holding 120,000,000 shares and have no problem if I lose that. Basher say it is a problem for me... hahaha 😆. Bahers are holding ZERO shares but come here every day, day after day posting the same stories over and over again and say to not believe those that are investing in GRST.
WARNING.. please do your own DD. It's the only thing bashers are right about.
declaes
2日前
25,000,000 revenues in 2025!!!
Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
declaes
2日前
GRST News: GRST TO PRESENT AT THE MICROCAP CONFERENCE
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies
Ethema to Present at Microcap Conference in Atlantic City on January 28-30, 2025
Ethema Health CorporationMon, January 20, 2025 at 3:00 PM GMT+1 3 min read
Ethema Health Corporation (OTCPINK:GRST) ("Ethema" "GRST" or the "Company"), is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Ethema's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
Ethema has substantially surpassed all projections it made at the 2024 Microcap conference. Mr. Leon will present on the significant impact that Ethema's recently acquired business Ethema Health Corporation (OTCPINK:GRST) ("Ethema" "GRST" or the "Company"), is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Ethema's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
Ethema has substantially surpassed all projections it made at the 2024 Microcap conference. Mr. Leon will present on the significant impact that Ethema's recently acquired business in Kentucky will have on the Company and the outlook for 2025 and beyond.
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
The 2025 event will feature:
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit https://themicrocapconference.com.
About Ethema Health Corporation
Ethema Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last decade and has had much success with in-patient treatment for adults. Ethema will continue to develop world class programs and techniques for North America. For more information you can visit our website at www.ethemahealth.com.
LandPro
1週前
An "OTC stock pumper" refers to an individual or group who deliberately promotes and artificially inflates the price of a stock that trades on the over-the-counter (OTC) market by spreading false or misleading information, often with the intention of selling their own shares at a higher price once the stock price rises, which is considered a fraudulent "pump and dump" scheme; essentially, they "pump" the stock price by creating hype to then "dump" their shares at a profit and leave other investors with losses.
Key points about OTC stock pumpers:
Low-regulated market:
OTC markets have less stringent regulations compared to major stock exchanges, making them more susceptible to manipulation by pumpers.
Microcap stocks:
Pumpers often target microcap stocks, which have small market capitalizations and limited public information, making them easier to manipulate.
False information tactics:
They may use various methods to spread false hype, including online forums, newsletters, email campaigns, and social media, claiming positive news about the company that isn't true.
Illegal activity:
Pump and dump schemes are considered securities fraud and are punishable by law, with the Securities and Exchange Commission (SEC) actively monitoring and prosecuting perpetrators.
Think1st
1週前
Grst is growing, you say its growing however with more and more debt
So either leave or stay and see where it goes, I understand a post once in awhile to scare some shares from someone , however day after day .is just not normal
.to read study all those financial statements with a forensic comb..for what? What gain do you have, to flip from 00004 to 00006
You can use your talent to buy options trade nvda or thousands of stocks.yet you are here non stop .vindictive, hate rules your world, you study every line , every comma, to find fault, study future earning. Shawn is the enemy for trying to help a drug clinic,???????? Is that it
Bubae
1週前
The last clean numbers before they included messy numbers from the acquisitions was in Q1 showing what the real cash burn is. Post# 50341 pinned at the top of this board is still relevant. In Q3 they needed $562,500 in new borrowing including the $250K the Leons had to kick in. The Mirage note earning default interest now of 24% a month is getting nasty. How long before Shawn Leon executes the revers split and regulation A offering plan he first talked about in the podcast January 2024? He has finally filed the reverse split notice, want to bet he sits on it for a few more months while this cash burning enterprise gets deeper in debt? If Shawn Leon were to ever make a timely decision I would fall out of my chair dead. 🤣
Bubae
Re: None
Sunday, December 29, 2024 3:19:07 PM
Post# 51690 of 51811
2024 was a very expensive year with completely borrowed cash. The plans at the beginning of 2024 didn't pan out with the offering so it is really beginning to bite once again. Shawn Leon wrapped the previous defaulted debt up into the crazy 2023 property purchase, sale, leaseback deal driving up quarterly expenses. Then in 2024 he piled on new debt to buy the new story that is attracting few buyers for the stock. Shawn Leon has always moved at a glacial pace while the debt goes into default which is why he and the misses had to personally guarantee the 2023 debt deal. Now the wife had to kick in another 250K to get through Q3 on top of the additional borrowing. Need another podcast to find out what Shawn Leon is up to for 2025. 😆
Bubae
1週前
Sorry, this one got boring short term. This ticker is on reverse slit watch after the 8K filing followed by the terms of the new regulation A offering that twill be pounding this anew with the dilution. I will however try to make more time available here. 😆 Please share? Reverse split is good news? Reverse split that Shawn Leon has been talking about for a year to support the badly needed revised regulation A offering? Details with links in Post# 51774 linked below. If you have good news why would you not post a link? 🤔
Where are the BASHERS when good news is announced, always missing?For the quarterly period ended September 30, 2024
https://www.otcmarkets.com/filing/html?id=17977812&guid=3D0-kKRdcsFTh3h#GRST_10Q_HTM_a_007
Over the next twelve months we estimate that we will require approximately $3.5 million for working capital and to repay existing short-term notes as the business continues to develop its rehab business in the US market. We have convertible notes, short term loans and promissory notes which will mature or have already matured during the current year and may have to raise equity or secure debt. There is no assurance that we will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on our financial condition. In the opinion of management, our liquidity risk is assessed as high due to this uncertainty.
Bubae
Re: pual post# 51767
Sunday, January 12, 2025 5:03:54 PM
Post# 51774 of 51810
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175654464
Interesting take Paul but I noticed that you completely ignore the regulation A offering narrative that went along with the reverse split. Among others, we have the Mirage note that matured November 15th earning default interest of 24% per month. Of course this violates the usual usury laws but in past notes the language tacks the portion not allowed onto the principle. That note would be approaching $1 million now. The split announcement leads me to believe that Shawn Leon finally worked a deal for someone to subscribe to an offering. You can bet that someone got a sweet deal to cover their risk because the story of this very expensive business model isn't selling. Those shares of the regulation A offering will be priced at a steep discount to market and will be free trading once issued.
declaes
1週前
Ethema Health Corporation (GRST): A Compelling Investment Opportunity
Ethema Health Corporation (OTCPINK: GRST) is a behavioral healthcare company specializing in the treatment of substance use disorders. With a unique approach to in-patient treatment for adults, Ethema has demonstrated significant growth and financial improvement, positioning itself as a strong candidate for investment.
Financial Performance and Growth
In the third quarter of 2023, Ethema reported a net income of $1,529,599 for the nine months ended September 30, 2023, a substantial turnaround from a net loss of $167,162 during the same period in 2022. This improvement is largely attributed to profits from the purchase and sale of real estate leased by its ARIA subsidiary. Additionally, the ARIA subsidiary reported an EBITDA of $883,603 for the nine months ended September 30, 2023, indicating robust operational performance.
Ethema's revenue for 2023 was $5.34 million, marking a 10.87% increase compared to the previous year's $4.82 million. Earnings also saw a significant rise, reaching $1.13 million, an increase of 652.42%.
Strategic Initiatives and Market Position
The company has been proactive in expanding its operations and strengthening its financial position. Notably, Ethema extended the closing on the purchase of real estate at 950 Evernia Street, aiming to utilize the property to eliminate debt and improve cash flow. Furthermore, the company is finalizing a lease location in Orlando, Florida, for a new facility, indicating a commitment to growth and market expansion.
Ethema is also working on raising new equity investment through its Reg A+ offering and strategic partnerships, priced above current market levels. This strategy reflects confidence in the company's valuation and future prospects.
Market Potential and Investment Consideration
Operating within the healthcare sector, specifically in medical care facilities, Ethema addresses a critical need in substance use disorder treatment. With a market capitalization of approximately $3.48 million and a 52-week stock price range between $0.0002 and $0.0010, the company presents a high-risk, high-reward investment opportunity.
Conclusion
Ethema Health Corporation's recent financial turnaround, strategic growth initiatives, and focus on expanding treatment facilities position it as a compelling investment opportunity in the behavioral healthcare sector. Investors seeking exposure to this market segment may find Ethema's current valuation and growth trajectory particularly attractive.
*Disclaimer: This article is for informational purposes only and should not be construed as financial advice. Potential investors should conduct their own due diligence before making any investment decisions.*
declaes
2週前
Ethema Health Corporation (OTC: GRST): A Promising Year of Growth and Strategic Expansion
Over the past year, Ethema Health Corporation (GRST) has made significant strides in its mission to provide cutting-edge treatment for substance use disorders. The company's strong performance, strategic acquisitions, and advancements in licensure position it as a notable contender in the behavioral healthcare industry. Here’s a look at GRST’s key milestones and positive developments from the past year.
---
Revenue Growth and Financial Improvements
GRST has demonstrated steady revenue growth, with a reported $5.34 million in revenue for the fiscal year 2023, marking a 10.87% increase compared to the prior year. This upward trajectory is complemented by a notable improvement in net income, which rose to $1.18 million, showcasing management's focus on profitability and operational efficiency.
Despite industry-wide challenges, GRST has continued to expand its asset base, with total assets increasing from $11.92 million in 2023 to $13.01 million as of Q3 2024. These financial indicators highlight the company’s resilience and growth potential.
---
Key Acquisition: Edgewater Recovery Center
In a strategic move to expand its reach, GRST successfully acquired the business assets of Edgewater Recovery Center LLC, located in Kentucky. This acquisition not only broadens the company’s geographic footprint but also solidifies its presence in a region with increasing demand for substance abuse treatment services.
---
ARIA Licensure Milestone
A major milestone for GRST this year was achieved by its subsidiary, the Addiction Recovery Institute of America (ARIA). The Boca Raton facility received full licensure for inpatient detoxification and residential Level 1 services, significantly enhancing its service offerings. This licensure paves the way for ARIA to attract a wider range of patients and tap into lucrative reimbursement opportunities from insurers.
---
Insider Confidence: Significant Share Purchases
Insider confidence in GRST’s growth potential was underscored by key transactions this year. Eileen Maria Greene, a related party, purchased 36,430,000 shares. Insiders are now holding 53% of the outstanding shares. This substantial investment signals strong belief in the company's long-term vision and operational strategy.
---
Commitment to Uplisting
In its efforts to increase visibility and attract institutional investors, GRST engaged the prominent law firm Blank Rome to assist with the process of uplisting its stock. This initiative reflects management’s ambition to enhance market presence and improve shareholder value.
---
Operational Highlights
GRST’s facilities have continued to deliver exceptional care, focusing on evidence-based treatment models that resonate with patients and healthcare providers alike. The company has reported higher occupancy rates at its centers, a testament to the growing demand for its services.
---
Outlook for 2025
As the behavioral healthcare industry evolves, GRST is well-positioned to capitalize on market opportunities. With its strategic acquisitions, expanded licensure, and improved financial health, the company is poised for continued growth. Analysts predict that GRST's focus on scalability and profitability could drive further investor interest in the coming year.
---
Conclusion
Ethema Health Corporation's performance in 2024 reflects its unwavering commitment to delivering high-quality substance use treatment and its dedication to strategic growth. With strong financial results, insider confidence, and expanding service capabilities, GRST stands out as a promising player in the healthcare sector.
Investors looking for opportunities in the behavioral healthcare industry should keep GRST on their radar as it builds momentum for an even stronger 2025.
Bubae
2週前
Your post history reveals that you are sitting on more than $100K of this trash. You are calling someone else a fool? 🙄After the split we will find out how cheap they will price the regulation A offering. The point of that article was lost on you apparently. Regulation A offering shares are exempt from registration thus free trading immediately when issued. After being diluted more than 100% by the Leons in July get ready for some more post split. That defaulted isn't going to pay for itself.
declaes
Re: A deleted message
Friday, July 05, 2024 2:03:32 PM
Post# 50390 of 51799
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174708577
Holding the bag??? Yes 116,000,000 shares at 0.0009. Still better than your 30,000 $OMID shares at 0.05 😂. You are a FOOL man.declaes
Re: Bubae post# 51453
Wednesday, November 20, 2024 10:54:28 AM
Post# 51459 of 51799
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175414480
Well now I have 120,000,000.just added some... tnx for the 0.0005s.
Bubae
2週前
Recently Paul? That was this morning and wasn't even for this stock this board. 🙄 That stock just did a reverse merger and the deal is contingent on the regulation A offering raising a minimum $1.5 million. To what extent would you pumpers here go to deceive others and attempt to discredit? If you do not know how regulation A offering s work you really shouldn't be trading a stock engaged in one.
The SEC has shut down the toxic notes the past few years charging many predatory lenders for acting as dealers while dumping unregistered shares into the market while converting their notes priced at an adjustable steep discount to market with each tranche. So toxic convertibles have dried up since the lenders can no longer dump the shares without the rule 144 holding period of 180 days without potential consequences. The new game is the regulation A offerings who shares once qualified by the SEC are legally exempt from registration and free trading. No matter how you try to depict it those are the facts.
Very recently you write: ''Amended regulation A offering. Haven't looked through it to see what is different.''
Not knowing what is or not different, you then write: ''Those reg A shares are exempt and will be immediately free trading. The subscriber will get them at a steep discount to the post split market price.'' The SEC is widening its war on toxic funders
Published on August 24, 2021
https://www.linkedin.com/pulse/sec-widening-its-war-toxic-funders-steve-taylor/
...it also increasingly utilized qualified Reg A offerings to acquire free-trading stock which they then dumped into the market without disclosure....
...This was a significant concern, as Reg A shares are immediately free-trading. That makes it much more attractive to many investors compared to restricted securities sold under Reg D exemptions, but it also is definitely more attractive to those looking to make a quick buck by breaking the law. This case demonstrates the SEC may not have been looking hard enough at the Reg A market for fraud, as certain financiers and funders have been scalping stock without disclosure in the filings....
...Section 17(b) of the Securities Act of 1933 requires anyone that is paid to promote a stock must disclose the amount of the payment and who paid them. This is probably the most violated SEC regulation, which is not a surprise as it is also the least enforced. Toxic funders routinely pay promoters to pump the stocks in which they are funding. ...
...To make money on their toxic convertible loan, these funders require volume to dump into. Lots of volume, because they have a lot of stock to sell. Thus the need for lots of promoters, most of whom are non-disclosing as telling the public they are getting paid to pump, and who paid them to do it, would scare even the most die-hard penny plunger away....
declaes
2週前
And a new license granted!!!
Looking to grow from 100 beds to 1000 beds in 2025 and goal of 5000 beds by 2027!!!
The Company recorded management fees for managing the Kentucky business in 2024, but will not report revenue for the business until the first quarter of 2025. Similarly, the Company's newly licensed operations in Boca Raton, Florida, did not receive approval to be added to the Company's existing payer contracts until January 2025, and therefore will not report revenue until 2025 either. Based on prior year revenues in both Kentucky and West Palm Beach, Florida, and the addition of the new beds in Boca Raton, Florida, the full year 2025 revenue target for all of the Company's facilities is $25,000,000.00
declaes
2週前
GRST bought a clinic that was mismanaged for the price of 250k worth 3,000,000 !!!!
560k revwill be transferred in1,400,000 rev per month in 2025. This was an insane great deal by GRST.
25,000,000 rev in 2025!!!
Ethema Completes Acquisition of Kentucky Treatment Operations
WEST PALM BEACH, FL - January 10, 2025 (NEWMEDIAWIRE) - Ethema Health Corporation's (OTCPINK: GRST) ("Ethema", "GRST" or the "Company") newly incorporated subsidiary ARIA Kentucky, LLC ("ARIA Kentucky") yesterday completed the purchase agreement with Edgewater Recovery Center LLC ("Edgewater"). The deal was previously announced in October 2024. The purchase price for the assets was $250,000.00 and included all cash, accounts receivable, vehicles, furniture and equipment valued at approximately $3,000,000, and assumed liabilities including bank debt, federal government debt and accounts payable of approximately $6,000,000. Ethema has managed Edgewater since July 15, 2024, when revenue was approximately $560,000 per month, with revenue increasing to approximately $830,000 in December 2024. The Company expects monthly revenue in Kentucky to increase by an additional 65% in the coming year by filling capacity at the existing facilities that are currently licensed and usable. The Kentucky assets have been rebranded under the ARIA name.
Bubae
2週前
I don't know why you keep posting that false nonsense. No new cash was realized with the Leons debt conversions to equity that resulted in a more than 100% dilution of the stock. Along with other borrowing for Q3 the Leons had to loan the company $250K to get through the quarter. If they can't get the reverse split and regulation A offering in order the Leons may need to break out the check books for some serious money soon. That $600K note alone that matured on November 15th is earning 24% default interest per month according to the filing.Regulation A offering is probably off the table after INSIDERS bought 53% of the OS.
Bubae
Re: declaes post# 51777
Monday, January 13, 2025 12:49:23 PM
Post# 51784 of 51790
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175657670
The Leons didn't exactly Buy-in. The diluted the stock by more than 100% in July with that deal for controlling interest. The Leons converted debt owed to them into majority ownership to do what they are doing now. That debt included the dubious claim of management fees that they declared forfeited in every filing. details with links in post# 51211 linked below. The company still owes the Leons more than $1 million and there is another $5 million plus in so called in friendly debt never were really "invested" in this. Shawn Leon spoke of converting the so called friendly debt into equity a year ago in the podcasts. In the latest 8K they increased the number of series B convertible preferred shares from 400,000 to 30 million. That is where the so called friendly debt will land. This takes the debt off the books and makes it look like they actually have some investors. When it is all done though these insiders really have nothing other than a cash burning enterprise if they are unable to con OTC retail to bail them out with the coming regulation A offering. These people should have lost their money long ago yet they are now maneuvering to get their money out. First, convert to convertible equity.Bubae
Re: Think1st post# 51656
Friday, December 06, 2024 11:30:26 AM
Post# 51658 of 51692
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175488284
Bed counts is the story Shawn Leon is trying to sell but it isn't getting any traction. The Kentucky acquisition was done for nothing so they were just looking for someone to take it over. Kentucky is cutting back on its Medicare payments to these facilities with the largest player closing some operations in that market. Podcast links in post# 51480 where Shawn Leon talks about the use of proceeds from the offering. He also talks about the split needed to support the offering. That is the real story here is it not? Take that and the fact that the CEO's wife kicked in another $250K last quarter to keep this story limping along. Looks to me like after two years of trying that Shawn Leon still is unable to find anyone to subscribe to that offering. Until then don't expect them to split the stock. On the other hand, know that when you see the split announcement that they have a deal in hand to move the new shares. Looks like retail is seeing through the story though so who will be buying the new dilution?
declaes
2週前
GRST2024
---------
revenues 5,000,000
Net profit 1,100,000
2025
---------
Revenues 25,000,000 (expected by cro)
Net profit 5,000,000 ?
But some idiots keep calling this a stincky pinky 🤣
Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
loanshark007
1日前
Penny2Dime
2日前
crowin
7日前
